FibroGen Valuation
| FGENDelisted Stock | USD 9.22 0.29 3.05% |
At this time, the firm appears to be overvalued. FibroGen shows a prevailing Real Value of $8.01 per share. The current price of the firm is $9.22. Our model computes the value of FibroGen from reviewing the firm fundamentals such as Profit Margin of 25.99 %, operating margin of (4.99) %, and Current Valuation of 86.86 M as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that FibroGen's price fluctuation is slightly risky at this time. Calculation of the real value of FibroGen is based on 3 months time horizon. Increasing FibroGen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since FibroGen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of FibroGen Stock. However, FibroGen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 9.22 | Real 8.01 | Hype 9.23 | Naive 9.35 |
The intrinsic value of FibroGen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence FibroGen's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of FibroGen helps investors to forecast how FibroGen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of FibroGen more accurately as focusing exclusively on FibroGen's fundamentals will not take into account other important factors: About FibroGen Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of FibroGen. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of FibroGen based exclusively on its fundamental and basic technical indicators. By analyzing FibroGen's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of FibroGen's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of FibroGen. We calculate exposure to FibroGen's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of FibroGen's related companies.FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California. Fibrogen Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 566 people.
FibroGen Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 100 M | |
| Quarterly Earnings Growth Y O Y | 0.536 | |
| Forward Price Earnings | 61.3497 |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in FibroGen Stock
If you are still planning to invest in FibroGen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the FibroGen's history and understand the potential risks before investing.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |